首页> 外文会议>IEEE Systems and Information Engineering Design Symposium >Identifying risk of progression for patients with Chronic Kidney Disease using clustering models
【24h】

Identifying risk of progression for patients with Chronic Kidney Disease using clustering models

机译:使用聚类模型确定慢性肾脏病患者的进展风险

获取原文

摘要

Chronic Kidney Disease ("CKD") and its comorbidities, diabetes, hypertension and cardiovascular disease ("CVD"), are frequently measured by routine procedures and lab tests, creating a large amount of historical data about this patient population. In this paper, we conducted a retrospective study based on Electronic Health Records ("EHR") data, in order to identify patterns in the development of CKD. In particular, we used a clustering approach to quantifiably identify diabetic patients who are at risk of progressing to advanced stages of CKD. Using values from routine measurements and lab tests such as systolic blood pressure, diastolic blood pressure, body mass index ("BMI"), Hemoglobin A1c ("HbAlc"), triglycerides and high density lipid cholesterol ("HDL cholesterol"), patients were classified into four clusters with a distinct separation between the cluster with the best value for each lab test and a cluster with the worst value for each lab test. We used lab values from each subsequent visit to calculate a progression score using the distance to the best and worst clusters, which indicated whether a patient's health was improving or deteriorating. We believe that this approach holds promise for future tools, as it is able to provide an ordered list of patients who are at greater risk of deterioration and should benefit from intervention by healthcare providers. The conclusions made in this paper are aimed at enabling timely monitoring and earlier intervention for patients that are associated with higher possibility of CKD progression.
机译:慢性肾脏病(“ CKD”)及其合并症,糖尿病,高血压和心血管疾病(“ CVD”)经常通过常规程序和实验室测试进行测量,从而产生了有关该患者人群的大量历史数据。在本文中,我们基于电子健康记录(“ EHR”)数据进行了回顾性研究,以便确定CKD的发展模式。特别是,我们使用了一种聚类方法来量化地确定有发展为CKD晚期风险的糖尿病患者。使用常规测量值和实验室测试的值,例如收缩压,舒张压,体重指数(“ BMI”),血红蛋白A1c(“ HbAlc”),甘油三酸酯和高密度脂质胆固醇(“ HDL胆固醇”),分为四个群集,每个实验室测试的值最高的群集和每个实验室测试的值最差的群集之间有明显的区别。我们使用随后每次访视的实验室值,使用到最佳和最差簇的距离来计算进展分数,这表明患者的健康状况是在改善还是在恶化。我们认为,这种方法为将来的工具带来了希望,因为它能够提供有更大恶化风险并应从医疗保健提供者的干预中受益的患者的有序列表。本文得出的结论旨在对与CKD病情恶化相关的患者进行及时监测和早期干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号